Hawley criticizes FDA’s Makary over having ‘no plans’ for abortion pills

Published



Sen. Josh Hawley (R-MO) criticized the new chief of the Food and Drug Administration, Dr. Marty Makary, on Thursday for saying that he does not yet have any policy plans regarding the controversial abortion pill, mifepristone. 

Makary said in an interview at the Semafor World Economy Summit that he has “no plans to take action” to restrict mifepristone, the pill used in nearly two-thirds of abortions in the United States.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.